Garo H. Armen - May 21, 2021 Form 4 Insider Report for AGENUS INC (AGEN)

Role
Chairman and Chief Executive Officer, Director
Signature
/s/Adam Krauss, as Attorney-in-Fact for Garo H. Armen
Stock symbol
AGEN
Transactions as of
May 21, 2021
Transactions value $
$14,791
Form type
4
Date filed
5/21/2021, 06:13 PM
Previous filing
May 7, 2021
Next filing
Jun 7, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGEN Common Stock Award $14.8K +3.53K +0.59% $4.19 604K May 21, 2021 Direct F1, F2
holding AGEN Common Stock 126K May 21, 2021 See Footnote F3
holding AGEN Common Stock 700K May 21, 2021 See Footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 As previously reported in the Current Report on Form 8-K filed with the Securities and Exchange Commission on January 14, 2021, Garo H. Armen's salary is being paid in stock, in lieu of cash, for the first half of 2021. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending May 21, 2021. Such shares are issued in accordance with the Agenus Inc. 2019 Equity Incentive Plan and are fully vested on the date of issuance.
F2 $4.19 is the closing price of our Common Stock on May 21, 2021, the payroll date for the pay period ending May 21, 2021.
F3 Shares are held in Dr. Armen's IRA accounts.
F4 Dr. Armen is trustee and has investment authority for the Garo Armen 2020 2 Year AG GRAT holder of 600,000 shares of our Common Stock. Dr. Armen is a general partner in Pixie Partners, a General Partnership ("Pixie"), which as of the date of this report owns 100,000 shares of our Common Stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Pixie and disclaims beneficial ownership to the extent of his pecuniary interest therein.

Remarks:

Chairman and Chief Executive Officer